Information regarding Coronavirus Disease

News

Dr. Erin Kobetz speaks at a Firefighter Cancer Initiative symposium while Dr. Alberto Caban-Martinez looks on.

Sylvester Researchers Collaborate with County to Provide Important COVID-19 Answers

When Miami Dade-County leaders set out to quantify the extent of COVID-19 infection in the county, they tapped researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine to lead this effort.

Read more about the collaboration »

Video & Photo Gallery

Miller School Physician Treats COVID-19 Patient with Nitric Oxide Therapy

A pulmonologist with the University of Miami Health System and the Miller School of Medicine has initiated a new therapy for the first time in a patient with novel coronavirus COVID-19 diagnosis. The treatment has the potential to delay the need for a ventilator.

Read more about the treatment »

Dr. Mauricio Cohen

Protecting Cardiology Patients and Staff During COVID-19

The COVID-19 pandemic is, at least temporarily, changing how everyone lives. Caution has become the operative word as people adjust their daily habits to maintain protective distance. The phrase “out of an abundance of caution” is now imprinted into the national consciousness.

Read more about how to protect cardiology patients and staff »

BOL Pharma’s center for growing medicinal cannabinoid.

Miller School Collaborates with BOL Pharma to Pioneer Research on Using CBD to Treat Concussion

One of the few manufacturers in the world that meets the high-quality research standards in the U.S. and Europe for medicinal cannabinoid (CBD) is collaborating with University of Miami Miller School of Medicine researchers, providing the company’s product for groundbreaking studies.

Read more about the research »

Dr. Murray Epstein

COVID-19 Alert: Heart and Kidney Patients Should Keep Taking Their Medicines

As the COVID-19 pandemic unfolds, inaccurate medical information has flooded social media and other channels. One potentially lethal example is that patients who take renin-angiotensin system (RAS) blockers, particularly angiotensin II type 1 receptor blockers (ARBs), may be more susceptible to the virus.

Read more about COVID-19 »

News Archives

Office of the Dean

A message from the dean

Physician News

Read Med News

e-Update

Read e-Update